MedTrace Logo

A Comparison of Bupivacaine and 2-chloroprocaine for Spinal Anesthesia

NCT00845962 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2010-01-27

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacity and the readiness for discharge between two local anesthetics, bupivacaine and 2-chloroprocaine, used for spinal anesthesia.

Conditions

  • Spinal Anesthesia

Interventions

DRUG

chloroprocaine

spinal administration of chloroprocaine 2%, 40 mg (2 mL)

DRUG

bupivacaine

spinal administration of bupivacaine 0,75% 7,5 mg (1 mL)

Sponsors & Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)

    collaborator OTHER

  • Université de Montréal

    lead OTHER

Principal Investigators

  • Jean-Denis Roy, MD · St-Luc hospital, CHUM, University of Montreal

  • Luc Massicotte, MD · St-Luc Hospital, CHUM, University of Montreal

  • Marie-Andrée Lacasse, MD, resident · St-Luc hospital, CHUM, University of Montreal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00845962 on ClinicalTrials.gov